Two years have passed since the Oncology Care Model (OCM), Medicare’s first cancer-specific alternative payment model, was officially launched with more than 190 participating practices. On this anniversary, we found it timely to compare the OCM with other value-based payment models (VBPMs) that have faced executional challenges in such a heterogeneously complex specialty as cancer.
Great enthusiasm to test innovative VBPMs exists in oncology. In a large systematic review,1 we found multiple examples of different payment and delivery models in cancer care, including bundled (or episode-based) payments, Accountable Care Organizations (ACOs), and oncology medical homes. Before comparing the OCM with these other models, it is important to define each of them. Bundled payments replace fee-for-service (FFS) payments with a fixed payment for a previously agreed set of services. In an ACO, clinicians are still reimbursed via FFS, but they have the potential for shared savings or losses based on their financial performance relative to previous years and regional benchmarks. A medical home is a health care delivery model that adheres to standards set by the National Committee for Quality Assurance and receives funding to support care enhancements in addition to FFS payments.
Aviki EM, Schleicher SM, Mullangi S. The Oncology Care Model and Other Value-Based Payment Models in Cancer Care. JAMA Oncol. 2019;5(3):298–299. doi:10.1001/jamaoncol.2018.5735
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: